UNSPSC 51152064: Orphenadrine citrate

This classification denotes a muscle relaxant with the molecular formula C18H23NO.C6H8O7, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X0A40N8I4S, chemically known as n,n-dimethyl-2-(o-methyl-.alpha.-phenylbenzyloxy)ethylamine hydrochloride but more generally known as orphenadrine citrate, which bears US NIH Compound Identifier 4601. European Medicines Agency schedules Orphenadrine citrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03546MIG.

UNSPSC 51152064 Orphenadrine citrate is a Commodity code that in practice covers pharmaceutical products and related medical supplies procured by state and local health agencies, though recent solicitation activity under this specific code is limited. The available record shows state and local governments acquiring naloxone and drug deactivation systems through this taxonomy entry, which represents a broader pattern of community health procurement rather than orphenadrine citrate specifically. Issuing bodies using this code include county health departments and community health programs that serve public health initiatives, particularly those addressing opioid response and harm reduction.

Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The solicitation closed July 26, 2023, and required vendors to submit bids through the county's e-Procurement Portal with all shipping costs included in pricing. Contractors must comply with drug-free workplace certification, E-Verify requirements, and maintain commercial general liability and workers' compensation insurance. The contract structure includes a two-year initial term with a one-year renewal option and a three-month probationary period allowing termination at will. Potential FEMA funding introduced additional federal compliance requirements under the Clean Air Act and Federal Water Pollution Control Act. No explicit set-aside designations were noted in the solicitation.